A Randomized, Double-blind Trial to Evaluate the Efficacy and Safety of Fixed Dose Rosiglitazone/Metformin Combination Therapy Compared to Both Rosiglitazone and Metformin Monotherapies in Drug Naive Type 2 Diabetes Mellitus Subjects
收藏DataCite Commons2025-03-17 更新2026-05-07 收录
下载链接：
https://search.vivli.org/doiLanding/studies/00000515/isLanding
下载链接
链接失效反馈官方服务：
资源简介：
The purpose of this 32 week study is to demonstrate that fixed-dose combination treatment with rosiglitazone/metformin will safely and effectively control glycemia as first line oral therapy in subjects type 2 diabetes. The primary objective of the study is to demonstrate superiority of rosiglitazone/metformin compared to its rosiglitazone and metformin.
提供机构：
Vivli
创建时间：
2018-10-27
